{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:46:08Z","timestamp":1792676768634,"version":"4.5.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/hco.0000000000000027","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T03:01:05Z","timestamp":1385434865000},"page":"20-27","source":"Crossref","is-referenced-by-count":75,"title":["Mechanisms of persistent atrial fibrillation"],"prefix":"10.1097","volume":"29","author":[{"given":"Jos\u00e9","family":"Jalife","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/clc.20138","article-title":"Update on atrial fibrillation: part I.","volume":"31","author":"Savelieva","year":"2008","journal-title":"Clin Cardiol"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heart.86.3.284","article-title":"Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database.","volume":"86","author":"Majeed","year":"2001","journal-title":"Heart"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the RenfrewPaisley study.","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2009.12.004","article-title":"Atrial fibrillation is independently associated with senile, vascular, and Alzheimers dementia.","volume":"7","author":"Bunch","year":"2010","journal-title":"Heart Rhythm"},{"key":"R7-4-20210204","first-page":"1982","article-title":"Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.","volume":"124","author":"Magnani","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"2012HRSEHRAECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.hrthm.2007.07.016","article-title":"Ablation of chronic atrial fibrillation.","volume":"4","author":"Matsuo","year":"2007","journal-title":"Heart Rhythm"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.hrthm.2007.04.005","article-title":"HRSEHRAECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation.","volume":"4","author":"Calkins","year":"2007","journal-title":"Heart Rhythm"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","article-title":"Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.","volume":"111","author":"Cappato","year":"2005","journal-title":"Circulation"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mayocp.2013.01.022","article-title":"Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies.","volume":"88","author":"Menezes","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0008-6363(01)00380-7","article-title":"The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation.","volume":"52","author":"Workman","year":"2001","journal-title":"Cardiovasc Res"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1161\/01.CIR.96.9.3157","article-title":"Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.","volume":"96","author":"Ausma","year":"1997","journal-title":"Circulation"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.85.5.428","article-title":"Atrial L-type Ca2 currents and human atrial fibrillation.","volume":"85","author":"Van Wagoner","year":"1999","journal-title":"Circ Res"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCEP.110.954636","article-title":"Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.","volume":"3","author":"Voigt","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2010.02.028","article-title":"In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.","volume":"55","author":"Caballero","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCEP.111.969519","article-title":"Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium.","volume":"5","author":"Filgueiras-Rama","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCRESAHA.110.234369","article-title":"Atrial fibrillation induces myocardial fibrosis through Angiotensin II type 1 receptor-specific arkadia-mediated downregulation of SMAD7.","volume":"108","author":"He","year":"2011","journal-title":"Circ Res"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"e55391","DOI":"10.1371\/journal.pone.0055391","article-title":"TGF-1, released by myofibroblasts, differentially regulates transcription and function of sodium and potassium channels in adult rat ventricular myocytes.","volume":"8","author":"Kaur","year":"2013","journal-title":"PLoS One"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.hrthm.2013.03.014","article-title":"Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts.","volume":"10","author":"Musa","year":"2013","journal-title":"Heart Rhythm"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.molmed.2011.05.007","article-title":"Inflammatory pathways underlying atrial fibrillation.","volume":"17","author":"Friedrichs","year":"2011","journal-title":"Trends Mol Med"},{"key":"R25-4-20210204","first-page":"465","article-title":"Arrhythmias in inflammatory heart disease in German; authors translation.","volume":"87","author":"Klein","year":"1975","journal-title":"Wien Klin Wochenschr"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation.","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.amjcard.2006.12.074","article-title":"Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.","volume":"99","author":"Loricchio","year":"2007","journal-title":"Am J Cardiol"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation.","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/jhh.2009.89","article-title":"Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.","volume":"24","author":"Rizos","year":"2010","journal-title":"J Hum Hypertens"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"R31-4-20210204","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11739-011-0557-z","article-title":"Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset.","volume":"8","author":"Pellegrino","year":"2013","journal-title":"Intern Emerg Med"},{"key":"R32-4-20210204","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.hrthm.2009.10.004","article-title":"Intracardiac and extracardiac markers of inflammation during atrial fibrillation.","volume":"7","author":"Marcus","year":"2010","journal-title":"Heart Rhythm"},{"key":"R33-4-20210204","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.104.2.174","article-title":"Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.","volume":"104","author":"Mihm","year":"2001","journal-title":"Circulation"},{"key":"R34-4-20210204","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1161\/hh1801.097644","article-title":"Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation.","volume":"89","author":"Carnes","year":"2001","journal-title":"Circ Res"},{"key":"R35-4-20210204","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.yjmcc.2008.07.007","article-title":"Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.","volume":"45","author":"Chen","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"R36-4-20210204","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition.","volume":"167","author":"Mentz","year":"2013","journal-title":"Int J Cardiol"},{"key":"R37-4-20210204","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.hrthm.2008.02.025","article-title":"The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.","volume":"5","author":"Iravanian","year":"2008","journal-title":"Heart Rhythm"},{"key":"R38-4-20210204","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2012.12.020","article-title":"Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation.","volume":"111","author":"Ito","year":"2013","journal-title":"Am J Cardiol"},{"key":"R39-4-20210204","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/hr.2010.277","article-title":"Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats.","volume":"34","author":"Kimura","year":"2011","journal-title":"Hypertens Res"},{"key":"R40-4-20210204","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","article-title":"Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"R41-4-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3317\/jraas.2003.025","article-title":"Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease.","volume":"4","author":"Pitt","year":"2003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R42-4-20210204","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.","volume":"51","author":"Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R43-4-20210204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehi668","article-title":"Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.","volume":"27","author":"Ehrlich","year":"2006","journal-title":"Eur Heart J"},{"key":"R44-4-20210204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(00)00158-9","article-title":"Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb).","volume":"48","author":"Frangogiannis","year":"2000","journal-title":"Cardiovasc Res"},{"key":"R45-4-20210204","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","article-title":"4th, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.","volume":"94","author":"Verheule","year":"2004","journal-title":"Circ Res"},{"key":"R46-4-20210204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cvr\/cvt074","article-title":"Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-beta1.","volume":"99","author":"Rahmutula","year":"2013","journal-title":"Cardiovasc Res"},{"key":"R47-4-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/HYPERTENSIONAHA.110.154609","article-title":"The soluble interleukin 6 receptor takes its place in the pantheon of interleukin 6 signaling proteins: phenoconversion of cardiac fibroblasts to myofibroblasts.","volume":"56","author":"Dixon","year":"2010","journal-title":"Hypertension"},{"key":"R48-4-20210204","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/dvdy.22280","article-title":"Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts.","volume":"239","author":"Santiago","year":"2010","journal-title":"Dev Dyn"},{"key":"R49-4-20210204","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00441-005-0144-6","article-title":"Extracellular matrix remodeling in canine and mouse myocardial infarcts.","volume":"324","author":"Dobaczewski","year":"2006","journal-title":"Cell Tissue Res"},{"key":"R50-4-20210204","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1139\/Y09-105","article-title":"Emerging concepts in cardiac matrix biology.","volume":"87","author":"Espira","year":"2009","journal-title":"Can J Physiol Pharmacol"},{"key":"R51-4-20210204","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","article-title":"Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.","volume":"107","author":"Dobaczewski","year":"2010","journal-title":"Circ Res"},{"key":"R52-4-20210204","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"R53-4-20210204","first-page":"325","article-title":"Collagen remodeling after myocardial infarction in the rat heart.","volume":"147","author":"Cleutjens","year":"1995","journal-title":"Am J Pathol"},{"key":"R54-4-20210204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.109.207456","article-title":"Intramyocardial fibroblast myocyte communication.","volume":"106","author":"Kakkar","year":"2010","journal-title":"Circ Res"},{"key":"R55-4-20210204","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell.","volume":"105","author":"Souders","year":"2009","journal-title":"Circ Res"},{"key":"R56-4-20210204","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1431927609990353","article-title":"The role of interleukin-6 in the formation of the coronary vasculature.","volume":"15","author":"Banerjee","year":"2009","journal-title":"Microsc Microanal"},{"key":"R57-4-20210204","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(94)90498-7","article-title":"Galectins: a family of animal beta-galactoside-binding lectins.","volume":"76","author":"Barondes","year":"1994","journal-title":"Cell"},{"key":"R58-4-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11897-010-0004-x","article-title":"Galectin-3 in cardiac remodeling and heart failure.","volume":"7","author":"de Boer","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"R59-4-20210204","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis.","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R60-4-20210204","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"R61-4-20210204","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-1 driven lung fibrosis by galectin-3.","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R62-4-20210204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.0.CO;2-0","article-title":"Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.","volume":"81","author":"Hsu","year":"1999","journal-title":"Int J Cancer"},{"key":"R63-4-20210204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2332\/allergolint.O-06-449","article-title":"Role of galectin-3 in human pulmonary fibrosis.","volume":"56","author":"Nishi","year":"2007","journal-title":"Allergol Int"},{"key":"R64-4-20210204","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/labinvest.3780131","article-title":"Galectin-1 and galectin-3 in chronic pancreatitis.","volume":"80","author":"Wang","year":"2000","journal-title":"Lab Invest"},{"key":"R65-4-20210204","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<481::AID-PATH263>3.0.CO;2-2","article-title":"Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by antithy1.1 antibodies.","volume":"187","author":"Sasaki","year":"1999","journal-title":"J Pathol"},{"key":"R66-4-20210204","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesiongrowth-regulatory lectin.","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R67-4-20210204","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","article-title":"Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.","volume":"14","author":"Lopez-Andres","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R68-4-20210204","first-page":"289","article-title":"Molecular biology of IgE-binding protein, IgE-binding factors, and IgE receptors.","volume":"10","author":"Liu","year":"1990","journal-title":"Crit Rev Immunol"},{"key":"R69-4-20210204","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.175.8.5390","article-title":"TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis.","volume":"175","author":"Bonniaud","year":"2005","journal-title":"J Immunol"},{"key":"R70-4-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"R71-4-20210204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"R72-4-20210204","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2174\/09298673113209990163","article-title":"Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives.","volume":"20","author":"Tellez-Sanz","year":"2013","journal-title":"Curr Med Chem"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0000000000000027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:42:38Z","timestamp":1620952958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201401000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0000000000000027","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}